NEW YORK (GenomeWeb News) — Applied Biosystems' parent company has sued Stratagene in the Netherlands and France for allegedly infringing an ABI patent, Stratagene said in a filing with the US Securities and Exchange Commission yesterday.
 
According to the filing, on May 23 Stratagene received a writ of summons filed by Applera in the District of The Hague in the Netherlands alleging that Stratagene's Mx3000P, Mx3005P, Mx4000P, and "certain related reagents" infringe ABI’s EU patent No. 0 872 562 B1.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.